Mirum Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Welcome, everyone. I'm Josh Schimmer from the Cantor biotech equity research team. Very pleased to introduce, from Mirum Pharmaceuticals, we have Eric Bjerkholt, the brand-new Chief Financial Officer; and Andrew McKibben, Vice President of Investor Relations and Finance, so welcome.
Questions & Answers
Lots of change in a short period of time at Mirum. Eric, why don't we start with you, as you're coming in, new to the company? Maybe talk a little bit about your near-term and long-term objectives.
Sure. Thank you and thank you for having us. And before I answer your question, let me say, we will be making forward-looking statements, so please refer to our SEC filings for the risk factors.
Let me start by saying I'm incredibly impressed by what this management team has accomplished in just a few years. And in fact, that made it very attractive for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
